Explore our comprehensive coverage of drug shortage, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
In June 2026, the global shortage of GLP-1 agonists officially ended as a wave of affordable biosimilars from international manufacturers flooded the ...
Read Full Story →PoliticsIn June 2026, the global shortage of GLP-1 agonists officially ended as a wave of affordable biosimi...
HealthcareIn June 2026, the global shortage of GLP-1 agonists officially ended as a wave of affordable biosimi...
HealthcareThe FDA has authorized compounding pharmacies to prepare customized, tiered-dose formulations of GLP...
